R5 Final QA

This page is part of the FHIR Specification (v5.0.0-draft-final: Final QA Preview for R5 - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

Example ArtifactAssessment/example-certainty-rating (Narrative)

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ArtifactAssessment.


Generated Narrative: ArtifactAssessment

Resource ArtifactAssessment "example-certainty-rating"

identifier: FEvIR Object Identifier: 27756

date: 2021-11-02T14:48:59.89Z

copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/

artifact: Evidence/18812: Critically appraised summary of all-cause mortality in meta-analysis of RCTs of heparin for moderately ill patients with COVID-19

content

informationType: rating

summary: serious concerns with risk of bias, inconsistency, and imprecision

type: Overall certainty (Evidence Certainty Type#Overall)

classifier: Very low quality (Evidence Certainty Rating#very-low)

author: : Brian S. Alper

freeToShare: true

Components

-InformationTypeSummaryTypeClassifierAuthor
*ratingrisk of bias in both included trialsRisk of bias (Evidence Certainty Type#RiskOfBias)serious concern (Evidence Certainty Rating#serious-concern): Brian S. Alper
*ratinghigh degree of heterogeneity (I-squared 80.7%) with confidence intervals of 2 trial effect estimates barely overlappingInconsistency (Evidence Certainty Type#Inconsistency)serious concern (Evidence Certainty Rating#serious-concern): Brian S. Alper
*rating Indirectness (Evidence Certainty Type#Indirectness)no serious concern (Evidence Certainty Rating#no-concern): Brian S. Alper
*rating95% confidence interval includes both large effects and no effectsImprecision (Evidence Certainty Type#Imprecision)serious concern (Evidence Certainty Rating#serious-concern): Brian S. Alper
*rating Publication bias (Evidence Certainty Type#PublicationBias)no serious concern (Evidence Certainty Rating#no-concern): Brian S. Alper

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.